GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 64 The complaints received during the year under review are as follows: Sr. No Particulars No. of Complaint 1 At the beginning of the year 00 2 Received during the year 87 3 Resolved during the year 87 4 Pending at the end of the year 00 7. GENERAL BODY MEETINGS Details of the location of the last three Annual General Meetings (AGM) and details of the resolutions passed or to be passed by Postal Ballot: Date Year Venue Time Special resolution 27 July 2021 1 April 2020 to 31 March 2021 At Registered Office - through Video Conferencing facility 2.30 p.m. — Commission to Independent Directors 27 July 2020 1 April 2019 to 31 March 2020 2.30 p.m. — None 22 July 2019 1 April 2018 to 31 March 2019 Birla Matushri Sabhagar, 19, Sir Vithaldas Thackersey Marg, Marine Lines, Mumbai – 400 020 2.30 p.m. — Re-appointment of Mr. Pradeep V. Bhide as an Independent Director — Re-appointment of Mr. Nihal Kaviratne CBE as an Independent Director — Re-appointment of Mr. Anami N. Roy as an Independent Director — Re-appointment of Mr. D. Sundaram as an Independent Director All the resolutions, including special resolutions set out in the respective Notices were passed by the shareholders. One Special Resolution is proposed to be passed at the forthcoming Annual General Meeting. Postal Ballot During FY 2021-2022, pursuant to the provisions of Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014, and any other applicable provisions of the Companies Act, 2013, below mentioned resolutions was passed by the members through postal ballot. The notice of the postal ballot dated 21 April 2021 & 26 July 2021 was sent to all members of the Company. P. N. Parikh of Parikh & Associates, Practicing Company Secretary, was appointed as the Scrutinizer for the Postal Ballots and submitted his report to Chairperson, Ms. R. S. Karnad. The results of the Postal Ballot were announced on 27 May & 15 September 2021, and the details are as follow: Description of the Resolution Votes in favour of the resolution Votes against the resolution Invalid votes Number of members voted Number of valid Votes cast (Shares) Percentage of total number of valid votes cast Number of members voted Number of valid Votes cast (Shares) Percentage of total number of valid votes cast Total number of members whose votes were declared invalid Total number of invalid votes cast (Shares) Special Resolution:- Sale and transfer of Business Undertaking 243 14,63,16,347 99.89 46 1,57,486 0.11 0 0 Ordinary Resolution:- Approval of Related Party Transactions 563 1,78,48,344 89.26 122 21,48,665 10.74 0 0 Means of Communication The quarterly and half-yearly results are published in widely circulating national and local dailies such as The Economic Times and Business Standard, in English and Maharashtra Times, in Marathi. These are not sent individually to the shareholders. The Company’s results and official news releases are displayed on the Company’s website at www. gsk-india.com . During the year, the Company held and made presentations at two institutional investor and analysts meetings, which is available on Company website at https://india-pharma.gsk. com/en-in/media/analysts-meets/ . The Management Discussion and Analysis Report form a part of this Annual Report. Annexure ‘C’ Report on Corporate Governance During the year under review, the above complaints regarding non-receipt of shares sent for transfer, demat queries and non-receipt of dividend warrants and annual reports were received from the shareholders, all of them were resolved. The Company had no transfers pending at the close of the financial year.